NAS10027,087+1.72%S&P7,401+0.65%GOLD$4,073−1.00%BTC$75,828−0.15%VIX24.55−12.88%latest tape · as of 20:03 UTC
The Screen · Communication Services · Telecom Services
LUMNLumen Technologies Inc
LUMN · the NYSE · USD · Market cap $4.7B · 21,000 employees
Lumen Technologies, Inc., a networking company, provides integrated products and services to business and mass customers in the United States and internationally.
FAIL · Does not pass the screen
3.98 USD
Price as of 5 Nov 2026Daily close, not a live quote
Screened 2026-11-05 · the tape above runs as of 20:03 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
Price3.98 USD at the 5 Nov 2026 close
Our value readUndervalued vs our fair value, as of 5 Nov 2026
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.34, read 2026-11-01
Ethical does not pass the values gate
Price3.98 USD
Fair value7.50
Ethical score70.0/100
Value readUndervaluedas of 5 Nov 2026
Our investment reviews on this name
2026-09-04Read Markdown6.81-41.6% to today ✓Distribution gives way to Markdown while volume still accumulates
2026-08-04Read Distribution6.56-39.3% to today ✓Markup gives way to Distribution after a 23% slide in 5 weeks
2026-07-02Read Markup8.49-53.1% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Lumen Technologies Inc holds its Markdown at $3.98. Consolidating, no directional conviction, held for 57 days.
As held on the ledger · 2026-11-05
Phase
Markdown · caution
Quantitative state
Consolidating, no directional conviction, held for 57 days
Price at the screen
$3.98
Valuation
N/A trailing · -15.81 forward price to earnings
Values screen
FAIL· score 70.0
Beta
1.86
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
51.56%
Below 33%
Interest-bearing debt is 51.6% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
6.72%
Below 49%
Money owed to the company is 6.7% of assets, under the 49% limit.
Pass
Revenue purity
0.60%
Below 5%
Only 0.6% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Lumen Technologies's business is in a permissible area, but its interest-bearing debt is about 52% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when LUMN's ethical verdict changes
Today LUMN does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 5 Nov 2026: it trades at roughly a 40% discount to our $7.50 fair value, narrow competitive moat.
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. A 46.9% discount to the base estimate.
Where our models see it going: fair-value estimate $7.50, with a range of $5.90 to $8.94, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Old networks struggle as demand fades fast
Picture a once busy switchboard now handling fewer calls each quarter. Lumen runs the cables and cloud edges that businesses and homes still use, yet revenue has dropped 9 percent while margins sit at negative 14 percent. The forward earnings multiple looks odd at negative 21.6 times because losses continue, and the narrow moat offers little protection against cheaper rivals.
We pass despite an ethical screen that clears and a claimed 35 percent gap to fair value. Ten analysts rate the shares a hold with an 8 dollar median target, but the business shows no clear path to growth and the opportunity rating stays at none. Declining top line and red ink outweigh any surface level discount.
Risk sits in execution and competition, with customers shifting to newer providers and capital needs staying high. The narrow moat cannot shield against ongoing revenue pressure. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
LUMN trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-04Markdown$4.75-2.7%Entry 17
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 2.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are up 89%. Our forward projection puts the odds of a 10% gain over the next month near 45%. The street (10 analysts) rates it none, with a mean price target of $8. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-03Markdown$4.88+0.0%Entry 16
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are up 89%. Our forward projection puts the odds of a 10% gain over the next month near 45%. The street (10 analysts) rates it none, with a mean price target of $8. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-02Markdown$4.88+0.0%Entry 15
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are up 89%. Our forward projection puts the odds of a 10% gain over the next month near 45%. The street (10 analysts) rates it none, with a mean price target of $8. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01Markdown$4.88+6.8%Entry 14
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 6.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are up 89%. Our forward projection puts the odds of a 10% gain over the next month near 45%. The street (10 analysts) rates it none, with a mean price target of $8. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-31Markdown$4.57+0.0%Entry 13
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are up 89%. Our forward projection puts the odds of a 10% gain over the next month near 45%. The street (10 analysts) rates it none, with a mean price target of $8. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-30Markdown$4.57+0.0%Entry 12
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are up 89%. Our forward projection puts the odds of a 10% gain over the next month near 45%. The street (10 analysts) rates it none, with a mean price target of $8. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29Markdown$4.57+0.0%Entry 11
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are up 89%. Our forward projection puts the odds of a 10% gain over the next month near 45%. The street (10 analysts) rates it none, with a mean price target of $8. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28Markdown$4.57+0.0%Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are up 89%. Our forward projection puts the odds of a 10% gain over the next month near 45%. The street (10 analysts) rates it none, with a mean price target of $8. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Markdown$4.57-8.4%Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 8.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 89%. Our forward projection puts the odds of a 10% gain over the next month near 45%. The street (10 analysts) rates it none, with a mean price target of $8.
2026-10-18Markdown$4.99-10.3%Entry 8
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 10.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 28% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 89%. Our forward projection puts the odds of a 10% gain over the next month near 45%. The street (10 analysts) rates it none, with a mean price target of $8.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.